Nagawa (9663.T) traded up 1.95 % during a 24 hours period ending at 09:40 PM Central Europe on Tuesday 27th. One Nagawa stock can currently be bought for about JPY 4,880 on popular exchanges. Current supply of Nagawa stocks is 15.3 mn. Nagawa has a current market capitalization of JPY 76 bn and approximately JPY 364.6 mn worth of Nagawa was traded on exchanges in the last 24 hours. Since last month end, Nagawa has traded 0.81 % up. Simple moving average of last 200 days is at JPY 5,377.92. The highest price of past 52 weeks was recorded at JPY 6,500 on 12/30/2025. 52 weeks low was at JPY 4,670 on 06/02/2026.

Summary of the latest news for Nagawa

NAGAWA CO LTD announced its financial results for the quarter ended 30 September 2026 on 26 October. The company reported a rise in earnings per share, moving from roughly 28 JPY a share in the same period last year to about 46 JPY this quarter, indicating improved profitability. Revenue also grew, with sales of around 8.9 billion JPY compared to 8.4 billion JPY in the prior year’s quarter. These developments suggest a positive trend in the company’s financial performance, with both earnings and sales showing upward movement relative to the previous year’s figures.

Here is how related stocks have performed in the past 24 hours:

  • Yahagi Construction (1870.T) traded up 1.34 % and now trades at JPY 2,111. Current market capitalisation for Yahagi Construction is JPY 91.2 bn. Current price/earnings ratio for Yahagi Construction is 10.26.

  • Nichiden (9902.T) traded up 1.12 % and now trades at JPY 3,175. Nichiden has a market capitalisation of JPY 90.4 bn. Current price/earnings ratio for Nichiden is 16.21.

  • Zeria Pharmaceutical (4559.T) traded up 0.3 % and now trades at JPY 1,985. Zeria Pharmaceutical has a market capitalisation of JPY 89.5 bn. Zeria Pharmaceutical has a current price to earnings ratio of 10.89. Zeria Pharmaceutical Co., Ltd., through its subsidiary Tillotts Pharma AG, has announced the planned acquisition of Haupt Pharma Wülfing GmbH in Gronau, Germany. The transaction aims to strengthen Zeria’s manufacturing base, enhance flexibility for future growth, and support long‑term supply security for its gastrointestinal drug portfolio. The agreement, signed on 23 October 2026, will integrate approximately 280 employees and expand production capacity for key products such as Asacol. While the purchase price remains undisclosed, Zeria intends to invest significantly in modernising the Gronau site, improving quality and efficiency, and preparing the facility for continued expansion. The move aligns with Zeria’s strategy to maintain a robust, specialised production network across multiple countries, ensuring reliable delivery of high‑quality therapeutic products to patients worldwide.

  • Arata (2733.T) traded up 0.71 % and now trades at JPY 2,668. Arata has a market capitalisation of JPY 89.9 bn. Current price/earnings ratio for Arata is 9.56.

  • Futaba Industrial (7241.T) traded down -0.6 % and now trades at JPY 1,004. Futaba Industrial has a market capitalisation of JPY 90 bn. Futaba Industrial has a current price to earnings ratio of 5.65.

About Nagawa

NAGAWA Co., Ltd. is a consumer discretionary company operating in the householder durables industry in Japan. The company primarily manufactures, sells, and rents unit houses branded as Super House. It also specializes in system module design and construction of buildings. In addition, Nagawa Co., Ltd. rents and sells construction machinery and equipment, as well as sells construction materials. The company also takes on remodeling, civil engineering, and various types of construction works. Previously known as Nagawa Sekiyu Corporation, the company changed its name to NAGAWA Co., Ltd. in March 1978. Founded in 1966, the headquarter of this Tokyo-based company is in Japan. The official website is www.nagawa.co.jp , and the company’s securities are traded on the Tokyo Stock Exchange. The Initial Public Offering (IPO) date for Nagawa Co., Ltd. was October 3rd, 1991.